$PFE Headlines Mega caps with mega recommendations 7:54

New Post Public Reply Private Reply Replies (0) Message Board

Aug 6, 2014 at 11:06 AM

$PFE Headlines

Mega caps with mega recommendations 7:54 a.m. Today - Mark Hulbert
Zoetis narrows full-year earnings guidance 8:12 a.m. Aug. 5, 2014 - MarketWatch.com
‘Inversion’ payoff for shareholders is muted at tax time 11:42 a.m. Aug. 3, 2014 - Laura Saunders
5 ways to profit from sex (without having it) 8:45 a.m. Aug. 3, 2014 - Charles Passy
AstraZeneca raises earnings view as sales rise 3:01 a.m. July 31, 2014 - MarketWatch.com
Pfizer to buy Baxter’s vaccines for $635 million 8:32 a.m. July 30, 2014 - Anna Prior
U.S. stocks end choppy trade lower 4:16 p.m. July 29, 2014 - Carla Mozee
Herbalife sinks on disappointing results; Darden gains 3:16 p.m. July 29, 2014 - Angela Johnson
Newscast: Investors await Fed meeting 10:01 a.m. July 29, 2014 - MarketWatch
Newscast: Wall Street may gain ground 7:35 a.m. July 29, 2014 - MarketWatch
Pfizer shares rise 1.3% in premarket trade after Q2 results 7:25 a.m. July 29, 2014 - Tomi Kilgore
Pfizer profit rises above estimates 7:24 a.m. July 29, 2014 - MarketWatch.com
The market in a minute: What will GDP mean for the market? 12:47 p.m. July 28, 2014 - The Trading Deck
Correction: Blog points out Valeant's diverse portfolio is key to its success 1:53 p.m. July 21, 2014 - blogs.marketwatch.com
Two rules of thumb for dumping your financial adviser 2:36 p.m. July 18, 2014 - Mark Hulbert
AbbVie, Shire set to announce merger as early as Friday: report 4:54 a.m. July 18, 2014 - blogs.marketwatch.com
Slim chances seen for tax 'inversion' clampdown, analysts say 10:58 a.m. July 16, 2014 - blogs.marketwatch.com
U.S. 'inversion' takeovers strike fear in Europe 4:03 a.m. July 15, 2014 - MarketWatch.com
U.K. ready to toughen up takeover rules 7:36 a.m. July 14, 2014 - Peter Evans
GoPro versus Twitter versus Facebook 2:01 p.m. July 3, 2014 - Mark Hulbert

Update: Pfizer Can Not Afford GlaxoSmithKline 9:03 a.m. Today - Seeking Alpha
Update: Pfizer Cannot Afford GlaxoSmithKline 9:03 a.m. Today - Seeking Alpha
Top Analyst Upgrades and Downgrades: Groupon, Micron, RingCentral, Target, Tesla, Monster, Pfizer and More 8:06 a.m. Today - 247WallSt.com
Jefferies Picks Top Franchise Stocks to Buy 7:32 a.m. Today - 247WallSt.com
Zoetis Profit Up on Strong U.S. Sales 6:27 p.m. Aug. 5, 2014 - The Wall Street Journal Interactive Edition
Drugmaker AstraZeneca Returns To Growth 4:22 p.m. Aug. 5, 2014 - Investors Business Daily
How Tax Inversions Became the Hottest Trend in M&A 3:34 p.m. Aug. 5, 2014 - The Wall Street Journal Interactive Edition
Zoetis Misses Marginally on Q2 Earnings, Up Y/Y, View Adjusted - Analyst Blog 3:00 p.m. Aug. 5, 2014 - Zacks.com
Widely Held Guru Stocks Near 52-Week Lows 9:51 a.m. Aug. 5, 2014 - GuruFocus.com
AstraZeneca Has 30% Upside As A Takeover Candidate 8:10 a.m. Aug. 5, 2014 - Seeking Alpha
Johnson & Johnson Can Only Get Better When It Gets Cheaper 6:00 a.m. Aug. 5, 2014 - TheStreet.com
Spin-Offs 101 And Value Creation 3:40 p.m. Aug. 4, 2014 - TheStreet.com
Dow 30 Stock Roundup: AmEx, XOM, PFE Beat on Earnings, CAT to Buy Back Shares - Analyst Blog 1:17 p.m. Aug. 4, 2014 - Zacks.com
3 Stocks Pulling The Drugs Industry Downward 1:03 p.m. Aug. 4, 2014 - TheStreet.com
American Express, Boeing, 5 Others Are Dragging Down the Dow 30 12:14 p.m. Aug. 4, 2014 - TheStreet.com
Walgreen Names New CFO Ahead of Possible Inversion 11:29 a.m. Aug. 4, 2014 - Investors Business Daily
Guru Stocks at 52-Week Lows: PFE, GSK, VOD, EC, UBS 10:12 a.m. Aug. 4, 2014 - GuruFocus.com
3 Stocks Reiterated As A Buy: PFE, REGN, PEP 9:59 a.m. Aug. 4, 2014 - TheStreet.com
Ken Fisher's Top Stock Picks 7:30 a.m. Aug. 4, 2014 - Seeking Alpha
Retirement Strategy: The ETF Only Portfolio Vs. Buy The Dips Portfolio: Update For July 8:33 a.m. Aug. 3, 2014 - Seeking Alpha

Pain Therapeutics Reports Q2 2014 Financial Results 8:01 a.m. Aug. 5, 2014 - GlobeNewswire
Depomed Announces Appointment of R. Scott Shively as Chief Commercial Officer 4:01 p.m. Aug. 4, 2014 - PR Newswire - PRF
Rascal Flatts Joins the Thousands of People Who Choose Nexium® 24HR Every Day for Their Frequent Heartburn 8:01 a.m. Aug. 4, 2014 - BusinessWire - BZX
Dividends, Upcoming Conference Schedules, Quarterly Earnings Releases, and Acquisitions - Research Reports on Wells Fargo, JPMorgan, Citigroup, Regions and Pfizer 9:10 a.m. July 31, 2014 - PR Newswire - PRF
InnoPharma Announces Launch of Olanzapine for Injection, 10mg/vial in Canada 10:33 a.m. July 30, 2014 - PR Newswire - PRF
Baxter Announces Divestiture of Commercial Vaccines Business to Pfizer 8:02 a.m. July 30, 2014 - BusinessWire - BZX
Pfizer Enters Into Agreement to Acquire Baxter’s Portfolio of Marketed Vaccines 8:02 a.m. July 30, 2014 - BusinessWire - BZX
BIOPHARMA INDUSTRY LEADER AMY SCHULMAN JOINS POLARIS PARTNERS 7:06 a.m. July 29, 2014 - GlobeNewswire
European Commission Approves Eliquis (apixaban) for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and Prevention of Recurrent DVT and PE 7:03 a.m. July 29, 2014 - BusinessWire - BZX
Global Women%s Health Market 2014-2018 6:20 p.m. July 28, 2014 - PR Newswire - PRF
Global Non-Hodgkin Lymphoma Therapeutics Market 2014-2018 4:00 p.m. July 28, 2014 - PR Newswire - PRF
Premier Biomedical Gears Up for Two Important Clinical Trials 8:04 a.m. July 25, 2014 - ACCESSWIRE
Partial Seizure Global Clinical Trials Review, H2, 2014 1:53 p.m. July 23, 2014 - PR Newswire - PRF
Intracerebral Hemorrhage Global Clinical Trials Review, H2, 2014 1:33 p.m. July 23, 2014 - PR Newswire - PRF
Generalized Tonic-Clonic Seizure Global Clinical Trials Review, H2, 2014 1:24 p.m. July 23, 2014 - PR Newswire - PRF
Generalized Seizures Global Clinical Trials Review, H2, 2014 1:17 p.m. July 23, 2014 - PR Newswire - PRF
Insomnia Global Clinical Trials Review, H2, 2014 1:14 p.m. July 23, 2014 - PR Newswire - PRF
Acquisition Agreements, Rejected Acquisition Tender Offers, Appointment, and Technical Updates - Research Reports on Pfizer, Gentiva, bluebird bio, Agios and AcelRx 8:30 a.m. July 23, 2014 - PR Newswire - PRF
Bristol-Myers Squibb and Pfizer Announce Enrollment of First Patient in Phase IV EMANATE Trial to Assess Effectiveness and Safety of Eliquis® (apixaban) in Patients with NVAF Undergoing Cardioversion 8:06 a.m. July 17, 2014 - BusinessWire - BZX
Pfizer to Acquire InnoPharma, Inc. 9:26 a.m. July 16, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

TCL Drives Fan Experience at FIBA Women's World Cup

TCL's Slam Dunk on the Global Stage The FIBA Women's Basketball World Cup 2026 in Berlin is set to showcase some incredible talent, and TCL is right in the thick of it. As a FIBA Global Partner, they're spearheading a new wave of fan interactions with their TCLforHer initiative, focusing on tech-enabled fan experiences that go beyond just watching the game. This isn't...

Asia-Pacific Media Forum Eyes Future Growth Strategies

Media Heavyweights Converge in Shenzhen Picture this: Over 400 media moguls from the Asia-Pacific region, huddled together in Shenzhen under that blazing September sun. What for? They're on a mission, inspecting China's shifting landscape, hunting down fresh growth avenues in the Guangdong-Hong Kong-Macao Greater Bay Area. It kicks off within the walls of the Asia-Pacific...

Consumer365 Lauds Happy Head's Custom Hair Treatments

Revolutionizing Hair Loss Treatment The world of hair growth solutions is transforming right before our eyes. Thanks to the folks over at Happy Head and their customizable, dermatologist-prescribed treatments, the days of one-size-fits-all are ending. Consumer365 recently took a dive into Happy Head's model, giving their nod of approval to its personalized approach....

Hims & Hers Faces Legal Storm Over Alleged Privacy Breaches

Legal Storms Brew Over Alleged Privacy Breaches Well, here we go again, folks. Just when you think the waters are calming, Hims & Hers Health, Inc. (NYSE: HIMS) finds itself in the thick of a nasty securities fraud class action lawsuit. Allegedly they've been less than honest with their customers' health info—something about sneaking around with people's sensitive data...

Ice-Rock Avalanches: Future Risks and Urgent Lessons

Mounting Threats in Mountain Chains That nightmare on August 26 at Mount Langtang Lirung in Nepal—where an ice-rock avalanche triggered a catastrophic mudslide—brought a harsh reminder that these mountains are cracking wide open. With 31 dead and over 500 souls still unaccounted for, it's a chilling warning about how vulnerable high-altitude regions have become. A...

Affleck Joins Aflac in Unlikely Yet Fitting Alliance

A Partnership Born from a Punning Connection Look, in this world of insurance and Hollywood glitz, it's not every day you see Ben Affleck sharing the screen with a talking duck. But here we are. Aflac—the giant in supplemental health insurance—and Ben Affleck have cozied up for a series of ads under Affleck’s direction, breathing life into what started as nothing...

Patented Foodservice Firm's $1.6M Sale: High ROI Potential

Cooking Up High Margins and Rapid Growth You don’t stumble on opportunities like this every day. A foodservice company out there is posting some mouth-watering numbers, and it’s shaking up the M&A scene. This one’s got patents holding up its brand like a culinary force field, and it’s now on the auction block for a cool $1.6 million. And the numbers? Well, they...

See's Candies Data Breach Spurs Legal Scrutiny

Data Breach Hits See's Candies Hard Amidst Ransomware Attack Alright, folks, here's a not-so-sweet tale to kick off your day — See's Candies has found itself in a bit of a pickle. A ransomware attack, the nasty kind that makes you double-check your locks and your passwords, has reportedly exposed the personal data of its customers and employees. We're talking names,...

Changhong's IFA 2026 Showcase: AI, Culture & Localization

Changhong's Game Plan: From Global Reach to Local Touch Well, Changhong's not sitting back at IFA 2026, let me tell you that. This isn't your run-of-the-mill showcase; it's a full-on reveal of what happens when a company takes AI tech and tunes it to the heartbeat of daily life. TVs, fridges, air conditioners—you name it, they've got an AI twist on it. But is this just...

UGREEN's AI Hub: Privacy-First Tech for Smart Homes

UGREEN's Big AI Leap In the bustling scene of home tech evolution, UGREEN's throwing its hat in the ring with its latest offerings. They've just rolled out the UGREEN HomeAgent series, aiming to redefine what we think of when it comes to smart living. UGREEN, usually known for its tech gadgets, is diving headfirst into the smart home pool. These local AI hubs blend tech...